Evolus Inc
NASDAQ:EOLS

Watchlist Manager

Evolus Inc

NASDAQ:EOLS

Watchlist

Dividends

Price: 9.43 USD 1.95%

Market Cap: 608m USD

Have any thoughts about
Evolus Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 9.43 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

EOLS Alert

Evolus Inc

9.43

+0.18 (+1.95%)

52 Week Range	9.19 17.49
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Evolus Inc

What unique competitive advantages
does Evolus Inc hold over its rivals?

What risks and challenges
does Evolus Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Evolus Inc.

What unique competitive advantages
does Evolus Inc hold over its rivals?

What risks and challenges
does Evolus Inc face in the near future?

Has there been any significant insider trading activity
in Evolus Inc recently?

Summarize the latest earnings call
of Evolus Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Evolus Inc.

Provide P/S
for Evolus Inc.

Provide P/E
for Evolus Inc.

Provide P/OCF
for Evolus Inc.

Provide P/FCFE
for Evolus Inc.

Provide P/B
for Evolus Inc.

Provide EV/S
for Evolus Inc.

Provide EV/GP
for Evolus Inc.

Provide EV/EBITDA
for Evolus Inc.

Provide EV/EBIT
for Evolus Inc.

Provide EV/OCF
for Evolus Inc.

Provide EV/FCFF
for Evolus Inc.

Provide EV/IC
for Evolus Inc.

Show me price targets
for Evolus Inc made by professional analysts.

What are the Revenue projections
for Evolus Inc?

How accurate were the past Revenue estimates
for Evolus Inc?

What are the Net Income projections
for Evolus Inc?

How accurate were the past Net Income estimates
for Evolus Inc?

What are the EPS projections
for Evolus Inc?

How accurate were the past EPS estimates
for Evolus Inc?

What are the EBIT projections
for Evolus Inc?

How accurate were the past EBIT estimates
for Evolus Inc?

Compare the revenue forecasts
for Evolus Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Evolus Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Evolus Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Evolus Inc compared to its peers.

Compare the P/E ratios
of Evolus Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Evolus Inc with its peers.

Analyze the financial leverage
of Evolus Inc compared to its main competitors.

Show all profitability ratios
for Evolus Inc.

Provide ROE
for Evolus Inc.

Provide ROA
for Evolus Inc.

Provide ROIC
for Evolus Inc.

Provide ROCE
for Evolus Inc.

Provide Gross Margin
for Evolus Inc.

Provide Operating Margin
for Evolus Inc.

Provide Net Margin
for Evolus Inc.

Provide FCF Margin
for Evolus Inc.

Show all solvency ratios
for Evolus Inc.

Provide D/E Ratio
for Evolus Inc.

Provide D/A Ratio
for Evolus Inc.

Provide Interest Coverage Ratio
for Evolus Inc.

Provide Altman Z-Score Ratio
for Evolus Inc.

Provide Quick Ratio
for Evolus Inc.

Provide Current Ratio
for Evolus Inc.

Provide Cash Ratio
for Evolus Inc.

What is the historical Revenue growth
over the last 5 years for Evolus Inc?

What is the historical Net Income growth
over the last 5 years for Evolus Inc?

What is the current Free Cash Flow
of Evolus Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Evolus Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

EOLS Price Targets Summary
Evolus Inc

Wall Street analysts forecast EOLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EOLS is 23.46 USD with a low forecast of 20.2 USD and a high forecast of 26.25 USD.

EOLS Average Forecast

Wall Street Target

23.46 USD

149% Upside

EOLS Highest Forecast

Wall Street Target

26.25 USD

178% Upside

Lowest

Price Target

20.2 USD

114% Upside

Average

Price Target

23.46 USD

149% Upside

Highest

Price Target

26.25 USD

178% Upside

Evolus Inc Competitors:
Price Targets

4886

ASKA Pharmaceutical Holdings Co Ltd

10% Upside

GLENMARK

Glenmark Pharmaceuticals Ltd

2% Upside

NATCOPHARM

Natco Pharma Ltd

18% Upside

REC

Recordati Industria Chimica e Farmaceutica SpA

11% Upside

4886

ASKA Pharmaceutical Holdings Co Ltd

10% Upside

GLENMARK

Glenmark Pharmaceuticals Ltd

2% Upside

NATCOPHARM

Natco Pharma Ltd

18% Upside

REC

Recordati Industria Chimica e Farmaceutica SpA

11% Upside

600436

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

31% Upside

MVP

Medical Developments International Ltd

44% Upside

002821

Asymchem Laboratories Tianjin Co Ltd

6% Upside

Revenue
Forecast

Revenue Estimate
Evolus Inc

The compound annual growth rate of Evolus Inc's revenue for the next 3 years is 31%.

N/A

Past Growth

31%

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Evolus Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

21%

Average Beat

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Evolus Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

What is EOLS's stock price target?

Price Target
23.46 USD

According to Wall Street analysts, the average 1-year price target for EOLS is 23.46 USD with a low forecast of 20.2 USD and a high forecast of 26.25 USD.

What is Evolus Inc's Revenue forecast?

Projected CAGR
31%

The compound annual growth rate of Evolus Inc's revenue for the next 3 years is 31%.

	Franklin Covey Co NYSE:FC	22.55 USD -1.31%
	Mohawk Industries Inc NYSE:MHK	99.52 USD 1.11%
	Ardmore Shipping Corp NYSE:ASC	10.565 USD 0.62%
	ASGN Inc NYSE:ASGN	49.78 USD -2.35%
	Skyworks Solutions Inc NASDAQ:SWKS	71.68 USD 0.21%
	Weatherford International PLC NASDAQ:WFRD	51.68 USD -0.14%

	Johnson & Johnson NYSE:JNJ	151.7 USD -0.45%
	Bank of America Corp NYSE:BAC	44.965 USD 1.66%
	Mastercard Inc NYSE:MA	549.09 USD -3.58%
	Salesforce Inc NYSE:CRM	258.745 USD -1.53%
	Abbvie Inc NYSE:ABBV	186.965 USD 0.8%
	Home Depot Inc NYSE:HD	349.095 USD 0.09%

	Arista Networks Inc NYSE:ANET	90.84 USD 1.29%
	Deckers Outdoor Corp NYSE:DECK	101.74 USD -0.85%
	Visa Inc NYSE:V	346.4581 USD -3.18%
	Texas Pacific Land Corp NYSE:TPL	1 089.97 USD 0.22%
	KLA Corp NASDAQ:KLAC	883.43 USD -1.07%
	Manhattan Associates Inc NASDAQ:MANH	188.335 USD -1.66%

	Salesforce Inc NYSE:CRM	258.745 USD -1.53%
	Accenture PLC NYSE:ACN	310 USD -0.65%
	ServiceNow Inc NYSE:NOW	983.935 USD -2.09%
	Spotify Technology SA NYSE:SPOT	710.8 USD -1.45%
	EOG Resources Inc NYSE:EOG	123.94 USD -0.56%
	Applied Materials Inc NASDAQ:AMAT	174.12 USD 0.02%

Evolus Inc
NASDAQ:EOLS